This article is available to subscribers. Subscribe now. Already have an account? Sign in

EditorialFree Preview

Shifting Tides Offer New Hope For Obesity

List of authors.
  • Clifford J. Rosen, M.D.,
  • and Julie R. Ingelfinger, M.D.

Obesity is a chronic disease affecting millions of people — in 2020, the Centers for Disease Control and Prevention (CDC) reported that the overall prevalence of obesity in the United States during the period from 2017 through 2018 was 42.5%.1 The development of type 2 diabetes is a complication of obesity that leads to greater mortality primarily due to a higher incidence of cancer, cardiovascular disease, and kidney disease2 The medical effects of obesity, especially type 2 diabetes, have a greater impact on some groups — particularly Black, Hispanic, and Native Americans — than on others, adding to notable health . . .

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Funding and Disclosures

Disclosure forms provided by the authors are available with the full text of this editorial at NEJM.org.

This editorial was published on June 4, 2022, at NEJM.org.

Author Affiliations

From Tufts University School of Medicine, Boston, and the Center for Clinical and Translational Research, Maine Medical Center Research Institute, Scarborough (C.J.R.).